These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 14598854)

  • 21. [French epidemiological bases for the treatment of dementia syndromes and cognitive impairment in the elderly].
    Dartigues JF; Orgogozo JM; Letenneur L; Barberger-Gateau P
    Therapie; 1993; 48(3):185-7. PubMed ID: 8140555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.
    Anstey KJ; von Sanden C; Salim A; O'Kearney R
    Am J Epidemiol; 2007 Aug; 166(4):367-78. PubMed ID: 17573335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Top 10 Facts You Should Know about Hearing Loss and Cognitive Decline.
    Sturdivant GG
    J Miss State Med Assoc; 2016 May; 57(5):142-4. PubMed ID: 27386667
    [No Abstract]   [Full Text] [Related]  

  • 25. [Can heart diseases a known effect on cognitive function?].
    Staszewski J
    Kardiol Pol; 2009 May; 67(5):494-5. PubMed ID: 19610250
    [No Abstract]   [Full Text] [Related]  

  • 26. Dementia: challenges and promising developments.
    Ballard C; Corbett A; Jones EL
    Lancet Neurol; 2011 Jan; 10(1):7-9. PubMed ID: 21163436
    [No Abstract]   [Full Text] [Related]  

  • 27. Cognitive impairment and dementia in Parkinson's disease.
    Marder K
    Mov Disord; 2010; 25 Suppl 1():S110-6. PubMed ID: 20187235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular risk factors and dementia in the general population aged >85 years: prospective population-based study.
    Rastas S; Pirttilä T; Mattila K; Verkkoniemi A; Juva K; Niinistö L; Länsimies E; Sulkava R
    Neurobiol Aging; 2010 Jan; 31(1):1-7. PubMed ID: 18378359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of dementia and associated risk factors in Middle Anatolia, Turkey.
    Arslantaş D; Ozbabalik D; Metintaş S; Ozkan S; Kalyoncu C; Ozdemir G; Arslantas A
    J Clin Neurosci; 2009 Nov; 16(11):1455-9. PubMed ID: 19748273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol for the older person--friend or foe?
    Chiu E
    Age Ageing; 2008 Sep; 37(5):493-4. PubMed ID: 18755781
    [No Abstract]   [Full Text] [Related]  

  • 31. Vascular risk factors and intensity of cognitive dysfunction in MCI.
    Siuda J; Gorzkowska A; Opala G; Ochudło S
    J Neurol Sci; 2007 Jun; 257(1-2):202-5. PubMed ID: 17335850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for vascular disease and dementia.
    Breteler MM; Bots ML; Ott A; Hofman A
    Haemostasis; 1998; 28(3-4):167-73. PubMed ID: 10420064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of cognitive deterioration in people over 80-years-old: COGMANLLEU study].
    Bufill E; Bartés A; Moral A; Casadevall T; Codinachs M; Zapater E; Rovira JC; Pérez R; Roura P; Blesa R
    Neurologia; 2009 Mar; 24(2):102-7. PubMed ID: 19322688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. I. Project to test exposure to risk factors for cardiovascular disease in the studied sample].
    Pajak A; Kawalec E; Szczudlik A
    Przegl Lek; 1998; 55(12):676-82. PubMed ID: 10354721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors.
    Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ;
    Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive predictors of dementia in elderly community residents.
    Dartigues JF; Commenges D; Letenneur D; Barberger-Gateau P; Gilleron V; Fabrigoule C; Mazaux JM; Orgogozo JM; Salamon R
    Neuroepidemiology; 1997; 16(1):29-39. PubMed ID: 8994938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-specific patterns and differences in dementia and Alzheimer's disease using informatics approaches.
    Ronquillo JG; Baer MR; Lester WT
    J Women Aging; 2016; 28(5):403-11. PubMed ID: 27105335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Brain aging, biological and psychosocial aspect].
    Costa E Silva JA
    Bull Acad Natl Med; 2005 Oct; 189(7):1371-9; discussion 1380-1. PubMed ID: 16669137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community environment, cognitive impairment and dementia in later life: results from the Cognitive Function and Ageing Study.
    Wu YT; Prina AM; Jones AP; Barnes LE; Matthews FE; Brayne C;
    Age Ageing; 2015 Nov; 44(6):1005-11. PubMed ID: 26464419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.